VAERS reports by lot

Merck HPV lot 1687291: VAERS reports

59 VAERS reports list lot 1687291 as a Merck HPV vaccine, received between 2021-01-07 and 2022-12-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
59
Reports
2%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1324%
Musculoskeletal1222%
General / Systemic (non-local)713%
Cardiac / Cardiovascular611%
Injection-site / Local reaction59%
Gastrointestinal47%
Allergic / Anaphylactic35%
Dermatological (non-injection-site)35%
Autoimmune / Immune-mediated12%
Respiratory12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Maryland12
New Mexico7
California6
Ohio3
Minnesota3
Virginia3
Massachusetts2
North Carolina2
Illinois2
Kentucky2
New York1
Oregon1

Reports by month received

2021-013
2021-0210
2021-033
2021-0411
2021-0515
2021-072
2021-084
2022-012
2022-031
2022-061
2022-072
2022-102
2022-112
2022-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.